QNRX

Quoin Pharmaceuticals Ltd. QNRX

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Top Institutional Holders

as of Q2 2026
$7.37M total
Stonepine Capital Management, LLC
$2.04M+1332.0%
Dauntless Investment Group, LLC
$1.04M+9.4%
Ikarian Capital, LLC
$1.02M0.0%
MILLENNIUM MANAGEMENT LLC
$543.6K+47.3%
SummitTX Capital, L.P.
$485.5K0.0%
Woodline Partners LP
$370.0K-3.9%
abrdn plc
$363.0K0.0%
Soleus Capital Management, L.P.
$352.0K0.0%
AIGH Capital Management LLC
$338.8K+37.3%
BOOTHBAY FUND MANAGEMENT, LLC
$289.6K0.0%
Velan Capital Investment Management LP
$156.7K-61.8%
BARCLAYS PLC
$103.9K+1551.5%
Birchview Capital, LP
$96.8K0.0%
XTX Topco Ltd
$72.6KNew
MORGAN STANLEY
$38.7K+100.0%
UBS Group AG
$32.8K+169.6%
RHUMBLINE ADVISERS
$11.3K+53.3%
GAMMA Investing LLC
$2.1K-74.5%
SBI Securities Co., Ltd.
$1.7KNew
See all 19 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/QNRX

Loading ratio trend…

QNRX insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About Quoin Pharmaceuticals Ltd. (QNRX): stock profile, AI score and financials

Quoin Pharmaceuticals Ltd. (QNRX) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. QNRX is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Top institutional holders of QNRX by reported 13-F value include Stonepine Capital Management, Dauntless Investment Group, Ikarian Capital, based on the most recent SEC filings. QNRX trades on the Nasdaq exchange and files with the SEC under CIK 1671502. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate QNRX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Quoin Pharmaceuticals Ltd. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1671502 →